Paper
Compound 9
RSC Advances
8.80 Hz, 8H), 3.89 (s, 12H). 13C NMR (100 MHz, CDCl3) d [ppm]:
158.66, 146.60, 141.42, 139.33, 134.73, 130.06, 128.30, 126.11,
125.35, 123.82, 120.44, 119.70, 118.41, 114.25, 112.13, 110.03,
55.40. MALDI-TOF MS (m/z): 921.795.
3,300,6,600-Tetrakis(4-methoxyphenyl)-90-tosyl-90H-9,3’:60,900-ter-
carbazole. A solution of compound 8 (1.16 g, 2.03 mmol) and
compound 6 (1.68 g, 4.42 mmol) in N,N-dimethylacetamide
(10 ml) was prepared. Copper oxide (0.59 g, 4.1 mmol) was added
to the solution. The mixture was then reuxed for 48 h and
cooled to room temperature. Aer cooling to room temperature,
the reaction mixture was evaporated under reduced pressure to
remove solvent and extracted with chloroform and water. The
organic layer was evaporated under reduced pressure, and the
residue was subjected to column chromatography using hexane/
ethyl acetate as the eluent to obtain the new compound as
a white solid (yield 49.1%, 1.07 g). Mp: decomposes >300 ꢁC. 1H
NMR (400 MHz, CDCl3) d [ppm]: 8.66 (d, J ¼ 8.80 Hz, 2H), 8.36 (d,
J ¼ 1.35 Hz, 4H), 8.18 (d, J ¼ 1.83 Hz, 2H), 7.98 (d, J ¼ 8.44 Hz,
2H), 7.83 (dd, J ¼ 8.93, 2.08 Hz, 2H), 7.66 (d, J ¼ 8.80 Hz, 8H),
7.63 (dd, J ¼ 8.25, 1.83 Hz, 4H), 7.46 (d, J ¼ 8.56 Hz, 4H), 7.35 (d,
J ¼ 8.07 Hz, 2H), 7.04 (d, J ¼ 8.80 Hz, 8H), 3.90 (s, 12H), 2.44 (s,
3H). 13C NMR (100 MHz, CDCl3) d [ppm]: 158.75, 140.74, 137.71,
135.05, 134.51, 134.08, 133.51, 130.17, 128.35, 128.29, 127.06,
126.82, 125.49, 125.46, 124.09, 118.88, 118.50, 116.47, 114.28,
109.87, 55.41, 21.73. MALDI-TOF MS (m/z): 1075.875.
Compound 12
3,300,6,600-Tetra-tert-butyl-90H-9,3’:60,900-tercarbazole. To a solu-
tion of compound 10 (1.39 g, 1.59 mmol) in 10 ml tetrahydro-
furan, dimethyl sulfoxide (4.8 ml) and water (1.6 ml) were
added, and the mixture was stirred for 10 min. Subsequently,
potassium hydroxide (1.59 g, 0.03 mol) was added to this
mixture, and the reaction mixture was reuxed for 4 hours,
cooled to room temperature and diluted with water. Aer
neutralization with HCl solution, the crude product was ltered
and recrystallized from dichloromethane–hexane (1 : 1) to give
the known compound 12 as a white solid (yield 99.5%, 1.14 g).
Mp: decomposes >300 C. H NMR (600 MHz, CDCl3) d [ppm]:
8.52 (br s, 1H), 8.18 (d, J ¼ 1.65 Hz, 6H), 7.70 (d, J ¼ 8.16 Hz, 2H),
7.63 (dd, J ¼ 8.48, 1.88 Hz, 2H), 7.47 (dd, J ¼ 8.57, 1.65 Hz, 4H),
7.33 (d, J ¼ 8.07 Hz, 4H), 1.48 (s, 36H). 13C NMR (100 MHz,
CDCl3) d [ppm]: 142.50, 140.19, 139.07, 125.97, 124.11, 123.54,
123.07, 119.43, 116.18, 111.84, 109.11, 102.16, 34.73, 32.05.
MALDI-TOF MS (m/z): 721.654.
1
ꢁ
Compound P1. Compound 1 (0.25 g, 0.51 mmol), carbazole 3
(0.48 g, 1.12 mmol), copper powder (0.13 g, 2.05 mmol), 18-
Crown-6 (0.013 g, 0.049 mmol) and K2CO3 (0.55 g, 4.0 mmol)
were dissolved in 4 ml anhydrous o-dichlorobenzene under
a nitrogen atmosphere. The reaction mixture was reuxed for
Compound 10
3,300,6,600-Tetra-tert-butyl-90-tosyl-90H-9,3’:60,900-tercarbazole.
A
solution of compound 8 (1.44 g, 2.51 mmol) and compound 7
(1.54 g, 5.5 mmol) in N,N-dimethylacetamide (10 ml) was
prepared. Copper oxide (0.73 g, 5.1 mmol) was added to the
solution. The mixture was then reuxed for 48 h and cooled to
room temperature. Aer cooling to room temperature, the
reaction mixture was evaporated under reduced pressure to
remove solvent and extracted with chloroform and water. The
organic layer was evaporated under reduced pressure, and the
residue was subjected to column chromatography using
hexane/ethyl acetate as the eluent to obtain the known
compound as a white solid with a yield of 65.5% (1.44 g). Mp:
decomposes >300 ꢁC. 1H NMR (600 M Hz, CDCl3) d [ppm]: 8.59
(d, J ¼ 8.80 Hz, 2H), 8.16 (d, J ¼ 1.65 Hz, 4H), 8.07 (d, J ¼ 2.02 Hz,
2H), 7.94 (d, J ¼ 8.25 Hz, 2H), 7.75 (dd, J ¼ 8.80, 2.20 Hz, 2H),
7.47 (dd, J ¼ 8.62, 2.02 Hz, 4H), 7.35 (d, J ¼ 8.25 Hz, 4H), 7.32 (d,
J ¼ 8.25 Hz, 2H), 2.42 (s, 3H), 1.48 (s, 36H). 13C NMR (100 MHz,
CDCl3) d [ppm]: 145.49, 143.02, 139.51, 137.38, 135.02, 134.54,
130.07, 127.09, 126.77, 123.70, 123.38, 118.50, 116.32, 108.97,
34.74, 32.00, 21.69. MALDI-TOF MS (m/z): 875.756.
ꢁ
72 h at 180 C. Aer cooling to room temperature, the mixture
was diluted in dichloromethane and ltered through silica gel.
The ltrate was evaporated under reduced pressure to give
a crude product, which was puried using column chromatog-
raphy to give the new compound as a white powdery product
(yield 20.1%, 0.123 g). Mp: decomposes >300 ꢁC. 1H NMR
(400 MHz, CDCl3) d [ppm]: 8.41 (d, J ¼ 1.47 Hz, 4H), 7.95 (d, J ¼
8.31 Hz, 4H), 7.46–7.80 (m, 38H), 1.42 (s, 36H). 13C NMR
(100 MHz, CDCl3) d [ppm]: 149.63, 140.32, 139.26, 138.98,
137.99, 136.48, 133.71, 133.55, 133.23, 130.09, 128.24, 126.95,
126.11, 125.77, 125.61, 124.25, 118.71, 110.25, 34.52, 31.43.
MALDI-TOF MS (m/z): 1195.097.
Compound P2. Compound 1 (0.20 g, 0.404 mmol), carbazole
4 (0.33 g, 0.86 mmol), copper powder (0.10 g, 1.57 mmol), 18-
Crown-6 (0.011 g, 0.042 mmol) and K2CO3 (0.44 g, 3.2 mmol)
were dissolved in 4 ml anhydrous o-dichlorobenzene under
a nitrogen atmosphere. The reaction mixture was reuxed for
Compound 11
ꢁ
3,300,6,600-Tetrakis(4-methoxyphenyl)-90H-9,3’:60,900-tercarba-
zole. To a solution of compound 9 (1.04 g, 0.965 mmol) in 9 ml
tetrahydrofuran, dimethyl sulfoxide (2.45 ml) and water (1.0 ml)
were added, and the mixture was stirred for 10 min. Subse-
quently, potassium hydroxide (1.36 g, 0.024 mol) was added to
this mixture, and the reaction mixture was reuxed for 4 hours,
cooled to room temperature and diluted with water. Aer
neutralization with HCl solution, the crude product was ltered
and recrystallized from dichloromethane–hexane (1 : 1) to give
the new compound as a white solid (yield 99.4%, 0.884 g). Mp:
72 h at 180 C. Aer cooling to room temperature, the mixture
was diluted in dichloromethane and ltered through silica gel.
The ltrate was evaporated under reduced pressure to give
a crude product, which was puried using column chromatog-
raphy to give the new compound as a white powdery product
1
ꢁ
(yield 27.7%, 0.122 g). Mp: decomposes >300 C. H NMR (600
MHz, CDCl3) d [ppm]: 8.43 (d, J ¼ 1.47 Hz, 4H), 7.96 (d, J ¼
8.25 Hz, 4H), 7.79 (dd, J ¼ 7.98, 1.56 Hz, 4H), 7.75 (d, J ¼
8.25 Hz, 4H), 7.72 (dd, J ¼ 8.53, 1.47 Hz, 4H), 7.64 (d, J ¼ 8.44,
4H), 7.51–7.60 (m, 6H), 7.40–7.46 (m, 4H), 7.35 (d, J ¼ 8.07 Hz,
4H), 7.29–7.31 (m, 4H), 6.94 (dd, J ¼ 8.25, 1.83 Hz, 4H), 3.94 (s,
12H). 13C NMR (100 MHz, CDCl3) d [ppm]: 160.06, 143.37,
140.58, 139.15, 138.03, 136.47, 133.76, 133.48, 133.39, 130.13,
1
ꢁ
decomposes >300 C. H NMR (600 MHz, CDCl3) d [ppm]: 8.62
(br s, 1H), 8.25–8.44 (m, 6H), 7.40–7.82 (m, 20H), 7.04 (d, J ¼
This journal is © The Royal Society of Chemistry 2018
RSC Adv., 2018, 8, 9850–9857 | 9855